CLASS III Drug recall · Reported 25 Sep 2013 · FDA Enforcement Report

Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg recalled

Watson Laboratories is recalling Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg, distributed nationwide in the US. The recall was initiated on 30 Aug 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 706224A and 706225A, Exp. 04/15.
Quantity recalled875 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1061-2013
FDA event ID
66169
Recalling firm
Watson Laboratories, Corona, CA
Classification
Class III
Status
Terminated
Recall initiated
30 Aug 2013
FDA classified
17 Sep 2013
Reported
25 Sep 2013
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Packaging Defects
Drug class
Pain Medication

Timeline

30 Aug 2013Recall initiated by company
17 Sep 2013Classified by FDA+18 days
25 Sep 2013Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Count Bottle, Manufactured by: Watson Laboratories, Inc, Cocona, CA 92880, NDC 0591-2611-05.

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Defective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.

Which lots are affected?

Lot 706224A and 706225A, Exp. 04/15.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Watson Laboratories

All 22

Other Hydrocodone Bitartrate recalls

All 19
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg recalledHydrocodone Bitartrate And AcetaminophenAscent PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIIHydrocodone Bitartrate and Homatropine Methlybromide recalledHydrocodone Bitartrate And Homatropine MethylbromideKvk-TechPotency & AssayNationwide
DrugCLASS IIHydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg recalledAscent PharmaceuticalsOtherNationwide
DrugCLASS IIHydrocodone Bitartrate and Homatropine Methlybromide Oral recalledHydrocodone Bitartrate And Homatropine MethylbromideKvk-TechParticulate MatterNationwide
DrugCLASS IIHydrocodone Bitartrate and Homatropine Methylbromide Oral recalledTorrent PharmaSterilityNationwide